F2RL1 and hepatocellular carcinoma: Based on our findings regarding the crucial role of PAR2 in TGF-β signaling, we would like to speculate on how disruption of the PAR2–TGF-β interaction could translate into future therapeutic strategies for PDAC and HCC.